We begin by understanding the decision behind the decision; what's really blocking a merger from closing cleanly, or a product from reaching market. We identify the real constraints through diligence, stakeholder input, and market analysis, then build the strategy around them.
01
Discover
We start by reviewing the deal, market, or go-to-market challenge from the inside, working with leadership to understand what's at stake and where the real risk sits.
Our Assessment Process
Life sciences advisory reviews across regulatory, commercial, and operational risk
Stakeholder interviews with leadership and deal teams
Market access and competitive landscape analysis
Post-merger systems and integration risk mapping
01
Discover
We start by reviewing the deal, market, or go-to-market challenge from the inside, working with leadership to understand what's at stake and where the real risk sits.
Our Assessment Process
Life sciences advisory reviews across regulatory, commercial, and operational risk
Stakeholder interviews with leadership and deal teams
Market access and competitive landscape analysis
Post-merger systems and integration risk mapping
01
Discover
We start by reviewing the deal, market, or go-to-market challenge from the inside, working with leadership to understand what's at stake and where the real risk sits.
Our Assessment Process
Life sciences advisory reviews across regulatory, commercial, and operational risk
Stakeholder interviews with leadership and deal teams
Market access and competitive landscape analysis
Post-merger systems and integration risk mapping
02
Design
With the risks understood, we build a strategy sized to the decision in front of you, an integration playbook for a merger, a launch model for a new product, a GTM plan for a new market.
How We Build the Strategy
M&A integration playbooks sequenced by system and process risk
Market access, pricing, and commercial launch modelling
Federal and commercial go-to-market strategy
Senior practitioner-led knowledge transfer plans for internal teams
02
Design
With the risks understood, we build a strategy sized to the decision in front of you, an integration playbook for a merger, a launch model for a new product, a GTM plan for a new market.
How We Build the Strategy
M&A integration playbooks sequenced by system and process risk
Market access, pricing, and commercial launch modelling
Federal and commercial go-to-market strategy
Senior practitioner-led knowledge transfer plans for internal teams
02
Design
With the risks understood, we build a strategy sized to the decision in front of you, an integration playbook for a merger, a launch model for a new product, a GTM plan for a new market.
How We Build the Strategy
M&A integration playbooks sequenced by system and process risk
Market access, pricing, and commercial launch modelling
Federal and commercial go-to-market strategy
Senior practitioner-led knowledge transfer plans for internal teams
03
Integrate
Our practitioners stay engaged through execution, working alongside your leadership and deal teams to keep integration or launch on schedule as complications surface.
What Embedded Strategy Support Looks Like
Senior practitioners embedded through close or launch
Integration workstreams tracked against a shared timeline
Direct knowledge transfer to internal commercial and regulatory teams
Real-time adjustment as market or deal conditions shift
03
Integrate
Our practitioners stay engaged through execution, working alongside your leadership and deal teams to keep integration or launch on schedule as complications surface.
What Embedded Strategy Support Looks Like
Senior practitioners embedded through close or launch
Integration workstreams tracked against a shared timeline
Direct knowledge transfer to internal commercial and regulatory teams
Real-time adjustment as market or deal conditions shift
03
Integrate
Our practitioners stay engaged through execution, working alongside your leadership and deal teams to keep integration or launch on schedule as complications surface.
What Embedded Strategy Support Looks Like
Senior practitioners embedded through close or launch
Integration workstreams tracked against a shared timeline
Direct knowledge transfer to internal commercial and regulatory teams
Real-time adjustment as market or deal conditions shift
04
Deliver
Impact is measured in what holds up after we leave: systems consolidated, a product commercially launched, a go-to-market strategy your team can run independently.
What We Deliver
Clinical and commercial systems consolidated post-merger
A commercial launch plan ready for execution
A go-to-market strategy owned by your internal team
Direct transfer of expertise to your internal team
04
Deliver
Impact is measured in what holds up after we leave: systems consolidated, a product commercially launched, a go-to-market strategy your team can run independently.
What We Deliver
Clinical and commercial systems consolidated post-merger
A commercial launch plan ready for execution
A go-to-market strategy owned by your internal team
Direct transfer of expertise to your internal team
04
Deliver
Impact is measured in what holds up after we leave: systems consolidated, a product commercially launched, a go-to-market strategy your team can run independently.
What We Deliver
Clinical and commercial systems consolidated post-merger
A commercial launch plan ready for execution
A go-to-market strategy owned by your internal team
Direct transfer of expertise to your internal team
Reach out to our team
Whether you're navigating complex systems, planning your next phase, or just have questions—we're ready to talk. Let us know how we can help.
Faris Bhatti
Managing Director
Faris Bhatti
Managing Director